| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Nov―15 |
Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires the exclusion of all differential diseases |
Josef Finsterer, Fulvio A Scorza |
| 2 |
[GO] |
2025―Sep―26 |
Emerging Enhancing Cerebral Lesions After Covid-19 Vaccination Should Entail Extensive Clarification |
Josef Finsterer |
| 3 |
[GO] |
2025―Aug―21 |
Attributing New Onset Myasthenia to Sars-Cov-2 Vaccination Requires Exclusion of Alternative Causes |
Josef Finsterer, Daniel Matovu |
| 4 |
[GO] |
2025―Aug―21 |
Sars-Cov-2 Vaccination Induced Gbs is a Severe Complication of All Types of Vaccines and Requires Prompt and Appropriate Treatment |
Josef Finsterer, Daniel Matovu |
| 5 |
[GO] |
2025―Aug―21 |
Is the Outcome of Sars-Cov-2 Associated Guillain-Barre Syndrome at Variance Between Rich and Poor? |
Josef Finsterer |
| 6 |
[GO] |
2025―Aug―21 |
Tocilizumab and Remdesivir can be More Harmful than Beneficial to COVID-19 Patients |
Josef Finsterer |
